Ligand Pharmaceuticals Incorporated

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
02/10/22 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions HTML PDF 4
02/10/22 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions HTML PDF 3
02/07/22 5 Annual statement of changes in beneficial ownership of securities HTML PDF 2
01/28/22 4 Statement of changes in beneficial ownership of securities HTML PDF 2
01/28/22 4 Statement of changes in beneficial ownership of securities HTML PDF 2
01/28/22 4 Statement of changes in beneficial ownership of securities HTML PDF 2
01/28/22 4 Statement of changes in beneficial ownership of securities HTML PDF 2
01/27/22 8-K Current report filing HTML PDF XBRL Viewer XLS XBRL Files 4
01/27/22 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions HTML PDF 5
01/25/22 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions HTML PDF 5
RSS